New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Form SC 13D Vitae Pharmaceuticals, Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
TRACON Pharmaceuticals Completes $27 Million Financing and Expands Management Team and Board of Directors
-
Form 4 SUNESIS PHARMACEUTICALS For: Aug 27 Filed by: New Enterprise Associates 12, Limited Partnership
-
Form 4 Tableau Software Inc For: Aug 20 Filed by: NEW ENTERPRISE ASSOCIATES 11 LP
-
Form SC 13D/A Epizyme, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form 4 CVENT INC For: Aug 14 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form 4 Epizyme, Inc. For: Aug 14 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13D Loxo Oncology, Inc. Filed by: New Enterprise Associates 14, L.P.
-
Loxo Oncology (LOXO) Prices 5.26M Common IPO at $13/Share
-
Form SC 13D Roka BioScience, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
8x8, Inc. (EGHT) Appoints New Director
-
Millennial Media (MM) CEO to Resign
-
Alimera Sciences (ALIM) Announces $40M Preferred Sale
-
Molycorp (MCP) Invests in Boulder Wind Power
-
Glu Mobile (GLUU) Reports Private Placement: to Sell 13.5M Shares at $1/Share
-
Sunesis Pharma (SNSS) Closes $28.5M Private Placement
-
Gen-Probe (GPRO) to Consolidate Industrial Assets Into New, Independent Company
-
Cadence Pharmaceuticals (CADX) to Raise $86.6 Million in a Private Placement

